Advertisement

Classification of Movement Disorders

  • Andrea E. Cavanna
Chapter

Abstract

Movement disorders characteristically result from dysfunction at the level of the basal ganglia and are classified into two broad groups: hypokinetic and hyperkinetic movement disorders. Patients with hypokinetic movement disorders have reduced movements, such as rigidity and akinesia/bradykinesia, which are primarily reported in the context of rigid-akinetic forms of Parkinson disease. Hyperkinetic movement disorders are characterised by excessive movements and include a wide range of motor manifestations, including tremor (rhythmic oscillatory movements), chorea (abrupt, purposeless, dance-like movements), athetosis (continuous, writhing movements, often involving the extremities and occasionally combined with chorea: ‘choreoathetosis’), tics (sudden, repetitive movements and vocalisations expressed following a sensory urge), dystonia (slow, twisting movements and abnormal postures caused by sustained or intermittent muscle contractions), myoclonus (brief shock-like jerks due to the sudden contraction or relaxation of one or more muscles), mannerisms (gestures and peculiar movements that individualise a person and are not usually considered bothersome), and stereotypies (patterned, repetitive, seemingly purposeless movements or utterances typically present in the context of autism spectrum disorders). Both neurodegenerative (Parkinson disease, Huntington disease) and neurodevelopmental (Tourette syndrome) movement disorders often present with specific behavioural symptoms which have a deep impact on patients’ health-related quality of life and highly benefit from a comprehensive neuropsychiatric approach.

Keywords

Basal ganglia Classification Hyperkinetic disorders Hypokinetic disorders Movement disorders 

Suggested Reading

Books

  1. Albanese A, Jankovic J, editors. Hyperkinetic movement disorders. Oxford: Wiley; 2012.Google Scholar
  2. Bédard M-A, Agid Y, Chouinard S, Fahn S, Korczyn AD, Lespérance P, editors. Mental and behavioral dysfunction in movement disorders. Totowa: Humana Press; 2003.Google Scholar
  3. Burn D, editor. Oxford textbook of movement disorders. Oxford: Oxford University Press; 2013.Google Scholar
  4. Donaldson IM, Marsden CD, Schneider SA, Bhatia KP. Marsden’s book of movement disorders. Oxford: Oxford University Press; 2012.CrossRefGoogle Scholar
  5. Fahn S, Jankovic J, Hallett M. Principles and practice of movement disorders. 2nd ed. Philadelphia: Elsevier; 2011.Google Scholar
  6. Kurlan RM, Green PE, Biglan KM. Hyperkinetic movement disorders. Oxford: Oxford University Press; 2015.CrossRefGoogle Scholar
  7. Martino D, Espay AJ, Fasano A, Morgante F. Disorders of movement. New York: Springer; 2016.CrossRefGoogle Scholar
  8. Reichmann H, editor. Neuropsychiatric symptoms of movement disorders. New York: Springer; 2015.Google Scholar
  9. Rogers D. Motor disorder in psychiatry: towards a neurological psychiatry. Chichester: John Wiley & Sons; 1992.Google Scholar
  10. Watts RL, Standaert DG, Obeso JA, editors. Movement disorders. 3rd ed. New York: McGraw-Hill; 2011.Google Scholar

Articles

  1. Abdo WF, van de Warrenburg BP, Burn DJ, Quinn NP, Bloem BR. The clinical approach to movement disorders. Nat Rev Neurol. 2010;6:29–37.CrossRefPubMedGoogle Scholar
  2. Cavanna AE. The behavioural neurology of basal ganglia disorders. Behav Neurol. 2013;26:217–8.CrossRefPubMedPubMedCentralGoogle Scholar
  3. Chou KL, Borek LL, Friedman JH. The management of psychosis in movement disorder patients. Expert Opin Pharmacother. 2007;8:935–43.CrossRefPubMedGoogle Scholar
  4. Fahn S. Classification of movement disorders. Mov Disord. 2011;26:947–57.CrossRefPubMedGoogle Scholar
  5. Jahanshahi M, Obeso I, Rothwell JC, Obeso JA. A fronto-striato-subthalamic-pallidal network for goal-directed and habitual inhibition. Nat Rev Neurosci. 2015;16:719–32.CrossRefPubMedGoogle Scholar
  6. Jankovic J. Treatment of hyperkinetic movement disorders. Lancet Neurol. 2009;8:844–56.CrossRefPubMedGoogle Scholar
  7. Jankovic J. Dopamine depleters in the treatment of hyperkinetic movement disorders. Expert Opin Pharmacother. 2016;17:2461–70.CrossRefPubMedGoogle Scholar
  8. Kieburtz K, Olanow CW. Advances in clinical trials for movement disorders. Mov Disord. 2015;30:1580–7.CrossRefPubMedGoogle Scholar
  9. Lanska DJ. The history of movement disorders. Handb Clin Neurol. 2010;95:501–46.CrossRefPubMedGoogle Scholar
  10. Macerollo A, Martino D. What is new in tics, dystonia and chorea? Clin Med. 2016;16:383–9.CrossRefGoogle Scholar
  11. Obeso JA, Rodriguez-Oroz MC, Stamelou M, Bhatia KP, Burn DJ. The expanding universe of disorders of the basal ganglia. Lancet. 2014;384:523–31.CrossRefPubMedGoogle Scholar
  12. Patel N, Jankovic J, Hallett M. Sensory aspects of movement disorders. Lancet Neurol. 2014;13:100–12.CrossRefPubMedPubMedCentralGoogle Scholar
  13. Pietracupa S, Bruno E, Cavanna AE, Falla M, Zappia M, Colosimo C. Scales for hyperkinetic disorders: a systematic review. J Neurol Sci. 2015;358:9–21.CrossRefPubMedGoogle Scholar
  14. Schroll H, Hamker FH. Basal ganglia dysfunctions in movement disorders: what can be learned from computational simulations. Mov Disord. 2016;31:1591–601.CrossRefPubMedGoogle Scholar
  15. Stoessl AJ, Mckeown MJ. Movement disorders. Handb Clin Neurol. 2016;136:957–69.CrossRefPubMedGoogle Scholar
  16. Stoessl AJ, Lehericy S, Strafella AP. Imaging insights into basal ganglia function, Parkinson’s disease, and dystonia. Lancet. 2014;384:532–44.CrossRefPubMedPubMedCentralGoogle Scholar
  17. Ward P, Seri S, Cavanna AE. Functional neuroanatomy and behavioural correlates of the basal ganglia: evidence from lesion studies. Behav Neurol. 2013;26:219–23.CrossRefPubMedPubMedCentralGoogle Scholar
  18. Wider C, Wszolek ZK. Movement disorders: insights into mechanisms and hopes for treatment. Lancet Neurol. 2009;8:8–10.CrossRefPubMedGoogle Scholar

Websites

  1. International Parkinson and Movement Disorders Society. www.movementdisorders.org

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Andrea E. Cavanna
    • 1
  1. 1.Dept of NeuropsychiatryUniversity of BirminghamBirminghamUnited Kingdom

Personalised recommendations